Magnetar Financial’s Edwards Lifesciences EW Stock Holding History

Magnetar Financial’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-93,401	Closed	-$7.3M	–	984
2025 Q2	$7.3M	Buy	+93,401	New	+$6.97M	0.04%	193
2024 Q4	–	Sell	-71,830	Closed	-$4.74M	–	670
2024 Q3	$4.74M	Buy	+71,830	New	+$5.22M	0.1%	158
2023 Q4	–	Sell	-12,884	Closed	-$893K	–	426
2023 Q3	$893K	Buy	+12,884	New	+$1.04M	0.02%	263
2021 Q1	–	Sell	-13,355	Closed	-$1.22M	–	1090
2020 Q4	$1.22M	Buy	+13,355	New	+$1.11M	0.02%	433
2020 Q3	–	Sell	-13,408	Closed	-$927K	–	673
2020 Q2	$927K	Buy	+13,408	New	+$953K	0.03%	196
2020 Q1	–	Sell	-20,475	Closed	-$1.59M	–	526
2019 Q4	$1.59M	Buy	+20,475	New	+$1.6M	0.03%	166
2017 Q4	–	Sell	-8,700	Closed	-$317K	–	760
2017 Q3	$317K	Buy	+8,700	New	+$332K	0.01%	517
2016 Q4	–	Sell	-15,285	Closed	-$614K	–	140
2016 Q3	$614K	Sell	15,285 -11,778	-44%	-$444K	0.01%	328
2016 Q2	$900K	Buy	27,063 +16,107	+147%	+$551K	0.01%	176
2016 Q1	$322K	Buy	10,956 +3,291	+43%	+$90.8K	0.01%	290
2015 Q4	$202K	Buy	+7,665	New	+$199K	﹤0.01%	332

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Magnetar Financial's EW Position: Q3 2025 in Review

Magnetar Financial sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 93,401 shares — an estimated $7.3M sold.

Magnetar Financial first reported a position in EW in Q4 2015 and held it in 11 quarters. The position peaked at $7.3M in Q2 2025. 1,255 funds tracked by Wall St. Rank hold EW as of Q3 2025.

Magnetar Financial reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
Magnetar Financial sold 93,401 Edwards Lifesciences shares in Q3 2025, an estimated $7.3M.
Magnetar Financial first reported a position in Edwards Lifesciences in Q4 2015 and held it in 11 quarters.
Magnetar Financial's Edwards Lifesciences position peaked at $7.3M in Q2 2025.
1,255 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Magnetar Financial's 13F filing for Q3 2025, filed 13 Nov 2025.